168 related articles for article (PubMed ID: 34356990)
21. A hyperactivating proinflammatory RIPK2 allele associated with early-onset osteoarthritis.
Jurynec MJ; Sawitzke AD; Beals TC; Redd MJ; Stevens J; Otterud B; Leppert MF; Grunwald DJ
Hum Mol Genet; 2018 Jul; 27(13):2383-2391. PubMed ID: 29659823
[TBL] [Abstract][Full Text] [Related]
22. XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures.
Ellwanger K; Briese S; Arnold C; Kienes I; Heim V; Nachbur U; Kufer TA
Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31350258
[TBL] [Abstract][Full Text] [Related]
23. RIPK2: a promising target for cancer treatment.
You J; Wang Y; Chen H; Jin F
Front Pharmacol; 2023; 14():1192970. PubMed ID: 37324457
[TBL] [Abstract][Full Text] [Related]
24. Cell death gene expression profile: role of RIPK2 in dengue virus-mediated apoptosis.
Morchang A; Yasamut U; Netsawang J; Noisakran S; Wongwiwat W; Songprakhon P; Srisawat C; Puttikhunt C; Kasinrerk W; Malasit P; Yenchitsomanus PT; Limjindaporn T
Virus Res; 2011 Mar; 156(1-2):25-34. PubMed ID: 21195733
[TBL] [Abstract][Full Text] [Related]
25. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.
Zhang W; Wang Y
Histochem Cell Biol; 2022 Feb; 157(2):173-182. PubMed ID: 34825931
[TBL] [Abstract][Full Text] [Related]
26. RIPK2 as a promising druggable target for autoimmune diseases.
Zhao W; Leng RX; Ye DQ
Int Immunopharmacol; 2023 May; 118():110128. PubMed ID: 37023697
[TBL] [Abstract][Full Text] [Related]
27. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
28. Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold.
Suebsuwong C; Dai B; Pinkas DM; Duddupudi AL; Li L; Bufton JC; Schlicher L; Gyrd-Hansen M; Hu M; Bullock AN; Degterev A; Cuny GD
Eur J Med Chem; 2020 Aug; 200():112417. PubMed ID: 32505849
[TBL] [Abstract][Full Text] [Related]
29. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer.
Li R; Liu B; Yin H; Sun W; Yin J; Su Q
J Mol Histol; 2013 Apr; 44(2):183-9. PubMed ID: 23108908
[TBL] [Abstract][Full Text] [Related]
31. NOD/RIPK2 signalling pathway contributes to osteoarthritis susceptibility.
Jurynec MJ; Gavile CM; Honeggar M; Ma Y; Veerabhadraiah SR; Novak KA; Hoshijima K; Kazmers NH; Grunwald DJ
Ann Rheum Dis; 2022 Oct; 81(10):1465-1473. PubMed ID: 35732460
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors.
Fan T; Ji Y; Chen D; Peng X; Ai J; Xiong B
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):282-293. PubMed ID: 36408835
[TBL] [Abstract][Full Text] [Related]
33. Optimization of a Series of RIPK2 PROTACs.
Miah AH; Smith IED; Rackham M; Mares A; Thawani AR; Nagilla R; Haile PA; Votta BJ; Gordon LJ; Watt G; Denyer J; Fisher DT; Dace P; Giffen P; Goncalves A; Churcher I; Scott-Stevens P; Harling JD
J Med Chem; 2021 Sep; 64(17):12978-13003. PubMed ID: 34432979
[TBL] [Abstract][Full Text] [Related]
34. RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases.
Honjo H; Watanabe T; Kamata K; Minaga K; Kudo M
Front Pharmacol; 2021; 12():650403. PubMed ID: 33935757
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
[TBL] [Abstract][Full Text] [Related]
36. Single-Nucleotide Polymorphisms in NOD1, RIPK2, MICB, PLCE1, TNF, and IKBKE Genes Associated with Symptomatic Dengue in Children from Colombia.
Useche YM; Ribeiro-Alves M; Restrepo BN; Salgado DM; Narváez CF; Campo O; Avendaño E; Martínez C; Chacon-Duque JC; Bedoya G
Viral Immunol; 2018 Nov; 31(9):613-623. PubMed ID: 30332343
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors.
Misehe M; Šála M; Matoušová M; Hercík K; Kocek H; Chalupská D; Chaloupecká E; Hájek M; Boura E; Mertlíková-Kaiserová H; Nencka R
Bioorg Med Chem Lett; 2024 Jan; 97():129567. PubMed ID: 38008339
[TBL] [Abstract][Full Text] [Related]
38. RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice.
Duggan BM; Cavallari JF; Foley KP; Barra NG; Schertzer JD
Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32473019
[TBL] [Abstract][Full Text] [Related]
39. Induction of RIP-2 kinase by proinflammatory cytokines is mediated via NF-kappaB signaling pathways and involves a novel feed-forward regulatory mechanism.
Yin X; Krikorian P; Logan T; Csizmadia V
Mol Cell Biochem; 2010 Jan; 333(1-2):251-9. PubMed ID: 19693652
[TBL] [Abstract][Full Text] [Related]
40. microRNA-210 and microRNA-3570 Negatively Regulate NF-κB-Mediated Inflammatory Responses by Targeting RIPK2 in Teleost Fish.
Su H; Chang R; Zheng W; Sun Y; Xu T
Front Immunol; 2021; 12():617753. PubMed ID: 33868233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
